NO996044L - Rapamycinformuleringer for oral administrasjon - Google Patents

Rapamycinformuleringer for oral administrasjon

Info

Publication number: NO996044L
Authority: NO; Norway
Prior art keywords: oral administration; rapamycin formulations; rapamycin; formulations; oral
Prior art date: 1997-06-13

Application number

NO996044A

Other languages

English (en)

Norwegian (no)

Other versions

NO996044D0 (no

Inventor

Arwinder Singh Nagi

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-13

Filing date

1999-12-08

Publication date

1999-12-08

1999-12-08 Application filed by American Home Prod filed Critical American Home Prod

1999-12-08 Publication of NO996044D0 publication Critical patent/NO996044D0/no

1999-12-08 Publication of NO996044L publication Critical patent/NO996044L/no

Links

238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 title 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title 1
229960002930 sirolimus Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO996044A 1997-06-13 1999-12-08 Rapamycinformuleringer for oral administrasjon NO996044L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US87496597A	1997-06-13	1997-06-13
PCT/US1998/012142 WO1998056358A1 (fr)	1997-06-13	1998-06-11	Formulations de rapamycine pour administration orale

Publications (2)

Publication Number	Publication Date
NO996044D0 NO996044D0 (no)	1999-12-08
NO996044L true NO996044L (no)	1999-12-08

Family

ID=25364977

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO996044A NO996044L (no)	1997-06-13	1999-12-08	Rapamycinformuleringer for oral administrasjon

Country Status (26)

Country	Link
EP (1)	EP0994697B1 (fr)
JP (1)	JP2002504124A (fr)
KR (1)	KR20010013650A (fr)
CN (1)	CN1133424C (fr)
AR (1)	AR012971A1 (fr)
AT (1)	ATE283687T1 (fr)
AU (1)	AU743584B2 (fr)
BR (1)	BR9810746A (fr)
CA (1)	CA2293793C (fr)
CZ (1)	CZ295276B6 (fr)
DE (1)	DE69827947T2 (fr)
DK (1)	DK0994697T3 (fr)
ES (1)	ES2232948T3 (fr)
HU (1)	HUP0003341A3 (fr)
IL (1)	IL132986A0 (fr)
NO (1)	NO996044L (fr)
NZ (1)	NZ501652A (fr)
PL (1)	PL337320A1 (fr)
PT (1)	PT994697E (fr)
RU (1)	RU2184541C2 (fr)
SK (1)	SK284472B6 (fr)
TR (1)	TR199903065T2 (fr)
TW (1)	TW574040B (fr)
UA (1)	UA65573C2 (fr)
WO (1)	WO1998056358A1 (fr)
ZA (1)	ZA985095B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH686761A5 (de)	1993-05-27	1996-06-28	Sandoz Ag	Galenische Formulierungen.
US20020013335A1 (en) *	2000-06-16	2002-01-31	American Home Products Corporation	Method of treating cardiovascular disease
EP1709974A3 (fr) *	2000-06-16	2006-12-06	Wyeth	Methode pour le traitement de maladies cardio-vasculaires en utilisant de la rapamycine
US6670355B2 (en)	2000-06-16	2003-12-30	Wyeth	Method of treating cardiovascular disease
JP4969747B2 (ja) *	2001-01-19	2012-07-04	武田薬品工業株式会社	錠剤フィルムコーティング用組成物
GB0123400D0 (en)	2001-09-28	2001-11-21	Novartis Ag	Organic compounds
PT1478648E (pt)	2002-02-01	2014-07-15	Ariad Pharma Inc	Compostos contendo fósforo e suas utilizações
GB0602632D0 (en) *	2006-02-08	2006-03-22	Pliva Istrazivacki Inst D O O	Preparation Of A Solid Dosage From Comprising Tacrolimus And/Or Sirolimus
CN102138903B (zh) *	2011-03-17	2012-12-12	苏州特瑞药业有限公司	一种依维莫司固体口服药物组合物
CN110585159B (zh) *	2019-09-12	2021-11-02	杭州华东医药集团新药研究院有限公司	一种含有西罗莫司的片剂
CN116236453A (zh) *	2023-02-08	2023-06-09	江苏和汇医药科技有限公司	一种延长药品释放的糖包衣及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU174057B (hu) *	1976-09-17	1979-10-28	Richter Gedeon Vegyeszet	Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
DK0525960T3 (da) *	1991-06-18	1996-04-15	American Home Prod	Anvendelse af rapamycin til behandling af T-celle leukæmi/lymfon
US5352783A (en) *	1993-06-09	1994-10-04	Merck & Co., Inc.	Microbial transformation product having immunosuppressive activity
US5536729A (en) *	1993-09-30	1996-07-16	American Home Products Corporation	Rapamycin formulations for oral administration
IL111004A (en) *	1993-09-30	1998-06-15	American Home Prod	Oral formulations of rapamycin
US5547948A (en) *	1995-01-17	1996-08-20	American Home Products Corporation	Controlled release of steroids from sugar coatings
CA2230748C (fr) *	1997-03-14	2010-08-03	American Home Products Corporation	Formulations de rapamycine pour administration orale

1998
- 1998-06-11 CA CA002293793A patent/CA2293793C/fr not_active Expired - Fee Related
- 1998-06-11 SK SK1717-99A patent/SK284472B6/sk unknown
- 1998-06-11 PT PT98926557T patent/PT994697E/pt unknown
- 1998-06-11 TR TR1999/03065T patent/TR199903065T2/xx unknown
- 1998-06-11 AR ARP980102784A patent/AR012971A1/es unknown
- 1998-06-11 AU AU78368/98A patent/AU743584B2/en not_active Ceased
- 1998-06-11 EP EP98926557A patent/EP0994697B1/fr not_active Expired - Lifetime
- 1998-06-11 IL IL13298698A patent/IL132986A0/xx unknown
- 1998-06-11 RU RU2000100944/14A patent/RU2184541C2/ru not_active IP Right Cessation
- 1998-06-11 PL PL98337320A patent/PL337320A1/xx unknown
- 1998-06-11 DK DK98926557T patent/DK0994697T3/da active
- 1998-06-11 JP JP50321399A patent/JP2002504124A/ja not_active Ceased
- 1998-06-11 ES ES98926557T patent/ES2232948T3/es not_active Expired - Lifetime
- 1998-06-11 ZA ZA9805095A patent/ZA985095B/xx unknown
- 1998-06-11 DE DE69827947T patent/DE69827947T2/de not_active Expired - Fee Related
- 1998-06-11 KR KR1019997011662A patent/KR20010013650A/ko not_active Abandoned
- 1998-06-11 BR BR9810746-1A patent/BR9810746A/pt active Search and Examination
- 1998-06-11 HU HU0003341A patent/HUP0003341A3/hu unknown
- 1998-06-11 TW TW087109298A patent/TW574040B/zh not_active IP Right Cessation
- 1998-06-11 WO PCT/US1998/012142 patent/WO1998056358A1/fr not_active Ceased
- 1998-06-11 CZ CZ19994502A patent/CZ295276B6/cs not_active IP Right Cessation
- 1998-06-11 AT AT98926557T patent/ATE283687T1/de not_active IP Right Cessation
- 1998-06-11 CN CNB988060965A patent/CN1133424C/zh not_active Expired - Fee Related
- 1998-06-11 NZ NZ501652A patent/NZ501652A/xx unknown
- 1998-11-06 UA UA2000010192A patent/UA65573C2/uk unknown
1999
- 1999-12-08 NO NO996044A patent/NO996044L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1998056358A1 (fr)	1998-12-17
RU2184541C2 (ru)	2002-07-10
CN1259864A (zh)	2000-07-12
BR9810746A (pt)	2000-09-19
EP0994697B1 (fr)	2004-12-01
NZ501652A (en)	2001-09-28
DE69827947D1 (de)	2005-01-05
ES2232948T3 (es)	2005-06-01
NO996044D0 (no)	1999-12-08
SK171799A3 (en)	2000-07-11
JP2002504124A (ja)	2002-02-05
DK0994697T3 (da)	2005-02-14
DE69827947T2 (de)	2005-04-21
CA2293793A1 (fr)	1998-12-17
UA65573C2 (uk)	2004-04-15
TR199903065T2 (xx)	2000-09-21
AU743584B2 (en)	2002-01-31
PL337320A1 (en)	2000-08-14
ATE283687T1 (de)	2004-12-15
AR012971A1 (es)	2000-11-22
CA2293793C (fr)	2006-07-11
CZ450299A3 (cs)	2000-08-16
CN1133424C (zh)	2004-01-07
ZA985095B (en)	1999-12-13
AU7836898A (en)	1998-12-30
HUP0003341A2 (hu)	2001-02-28
SK284472B6 (sk)	2005-04-01
PT994697E (pt)	2005-02-28
KR20010013650A (ko)	2001-02-26
TW574040B (en)	2004-02-01
CZ295276B6 (cs)	2005-06-15
EP0994697A1 (fr)	2000-04-26
HUP0003341A3 (en)	2001-03-28
IL132986A0 (en)	2001-03-19

Legal Events

Date	Code	Title	Description
2007-01-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO992339L (no)	1999-11-16	Farmasöytiske formuleringer
BR9610153A (pt)	1999-01-05	Formulações farmacêuticas
BR9611626A (pt)	1999-06-01	Formulações farmacéuticas
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
EE04901B1 (et)	2007-10-15	Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
DE59712959D1 (de)	2008-09-25	Orale pharmazeutische zubereitung enthaltend ibandronat
NO993096D0 (no)	1999-06-22	Orale cyklosporinformuleringer
DE69822172D1 (de)	2004-04-08	Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
DK0907364T3 (da)	2002-11-11	Farmaceutiske præparater med langvarig frigivelse indeholdende et dibenzothiazepinderivat
NO20015670D0 (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
EE05375B1 (et)	2011-02-15	LevosimendaniÁfarmatseutilineÁlahus
ATE223705T1 (de)	2002-09-15	Rapamycin enthaltende formulierungen zur oralen verabreichung
ATE263550T1 (de)	2004-04-15	Orale cyclosporinformulierungen
FI944534A7 (fi)	1995-03-31	Rapamysiinikoostumuksia oraalisesti annettaviksi
FI944535L (fi)	1995-03-31	Rapamysiinikoostumuksia oraalisesti annettaviksi
NO996044L (no)	1999-12-08	Rapamycinformuleringer for oral administrasjon
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
ID30032A (id)	2001-11-01	Formulasi farmasi
DE69830154D1 (de)	2005-06-16	Pharmazeutische zusammensetzungen
NO20003284D0 (no)	2000-06-22	Farmasøytisk preparat for oral administrering
HK1025911A (en)	2000-12-01	Rapamycin formulations for oral administration
SE9502453D0 (sv)	1995-07-06	Drug formulations
SE9404467D0 (sv)	1994-12-22	Drug formulations